APSR2026-620

 
Late-Breaking
Submitted
Oral Presentation
AO25-003
 
 
https://storage.unitedwebnetwork.com/files/1285/1220978-46903-APSR-620_440213.pptx
Format: PPTX Only
 
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
5

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Chloe Cheong * The Royal Melbourne Hospital Department of Respiratory and Sleep Disorders Medicine Melbourne Australia
Kasha Singh - The Royal Melbourne Hospital Victorian Infectious Diseases Service Melbourne Australia
Katherine Bond - The Royal Melbourne Hospital Victorian Infectious Diseases Service Melbourne Australia
Katherine Huang - The University of Melbourne Department of Biochemistry and Pharmacology Melbourne Australia
Megan Rees - The Royal Melbourne Hospital Department of Respiratory and Sleep Disorders Medicine Melbourne Australia
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Chloe
Cheong
ccheong2701@gmail.com
+61432528348
Under 30
Australia
Original Research
Evaluating and predicting disease progression of non-tuberculous mycobacterial lung disease in cases from the royal melbourne hospital
Maximum 25 words
Abstract Content
Non-tuberculous Mycobacteria (NTM) are environmental organisms commonly found in soil, dust, and water (Tan S et al, Seminars in Respiratory and Critical Care Medicine, 2021, 42, 567–586). NTM commonly presents as pulmonary disease (NTMPD). NTMPD has high morbidity and mortality and is increasing in incidence worldwide (Ratnatunga CN et al, Frontiers in Immunology, 2020, 11, 303). Given the highly heterogenous clinical course of the disease and the toll of prolonged and often poorly tolerated antibiotic therapy, identification of variables contributing to prognosis is clinically beneficial (Kim HJ et al, American Journal of Respiratory and Critical Care Medicine, 2021, 203, 230–236). The aim of this research is to identify clinical, radiological, and microbiological factors associated with mortality, treatment, culture conversion, and other relevant outcomes in a cohort of adults with NTMPD at the Royal Melbourne Hospital between 2017 to 2026. Additionally, the study aims to validate an existing prognostic model for NTMPD, the BACES score, in this cohort (Kim HJ et al, American Journal of Respiratory and Critical Care Medicine, 2021, 203, 230–236).
We included patients with an NTM positive pulmonary sample at the Royal Melbourne Hospital between 2017 to 2026. Patient data was collected from electronic medical records and included demographics such as sex and age, comorbidities, symptoms, diagnosis, and treatment. Feature selection identified predictors and a multivariate analysis was used to construct a prognostic model for outcomes including mortality, treatment initiation, and culture conversion. External validation of the BACES score was performed using a Kaplan-Meier survival analysis and Harrell’s C-index.
Data analysis is ongoing; however, preliminary findings indicate that survival curves show clear separation of BACES scores in this cohort.
Findings from this study are expected to provide insight into the validity of the BACES score in a novel cohort. Generated prognostic models will also be used to educate future clinical decision-making for NTMPD at the Royal Melbourne Hospital.
 
 
 
 
 
Yes
No
 
JPG or JPEG or PNG format ONLY
Nontuberculous Mycobacterial Pulmonary Disease, Risk Prediction Model, BACES Score
maximum 3 keywords and no abbreviations, separated by commas
 
313